Option chain shows key data for Cadeler's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Cadeler.

Cadeler (OTC:CADLF) Stock, Option Chain

Cadeler AS is an offshore wind farm vessel contractor. It is engaged in offshore wind farm construction, maintenance, and decommissioning, and provides marine and engineering operations to the wind industry with a focus on safety and the environment. The company operates four offshore jack-up wind farm installation vessels. In addition to wind farm installation, these vessels can perform maintenance, construction, decommissioning, and other tasks within the offshore industry.

Cadeler AS

Mizuho analyst Vikram Malhotra upgrades Cousins Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CUZ#NYSE">CUZ</a>) from Underperform to Neutral and raises the price target from $22 to $30.

News

Upgrades

Price Target

Analyst Ratings

Mizuho Upgrades Cousins Props to Neutral, Raises Price Target to $30

JP Morgan analyst Kenneth Worthington upgrades P10 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PX#NYSE">PX</a>) from Neutral to Overweight and raises the price target from $14 to $15.

JP Morgan Upgrades P10 to Overweight, Raises Price Target to $15

HC Wainwright &amp; Co. analyst Mitchell Kapoor reiterates CytomX Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTMX#NASDAQ">CTMX</a>) from Neutral to Neutral.

Reiteration

CTMX

HC Wainwright & Co. Reiterates Neutral on CytomX Therapeuticsto Neutral

Jefferies analyst Kelly Shi upgrades Instil Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIL#NASDAQ">TIL</a>) from Hold to Buy and raises the price target from $11 to $52.

Jefferies Upgrades Instil Bio to Buy, Raises Price Target to $52

Apogee Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APOG#NASDAQ">APOG</a>) reported quarterly earnings of $1.19 per share which beat the analyst consensus estimate of $1.12 by 6.25 percent. The company reported quarterly sales of $341.344 million which beat the analyst consensus estimate of $332.628 million by 2.62 percent. This is a 0.48 percent increase over sales of $339.714 million the same period last year.

Earnings

Earnings Beats

APOG

Apogee Enterprises Q3 2025 Adj. EPS $1.19 Beats $1.12 Estimate, Sales $341.344M Beat $332.628M Estimate

Needham analyst Mike Cikos reiterates GitLab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>) with a Buy and maintains $85 price target.

GTLB

Needham Reiterates Buy on GitLab, Maintains $85 Price Target

Jefferies analyst David Hove upgrades Royal Gold (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGLD#NASDAQ">RGLD</a>) from Hold to Buy and raises the price target from $154 to $178.

RGLD

Jefferies Upgrades Royal Gold to Buy, Raises Price Target to $178

Needham analyst David Saxon reiterates Staar Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STAA#NASDAQ">STAA</a>) from Hold to Hold.

STAA

Needham Reiterates Hold on Staar Surgicalto Hold

$BTC

$ETH

BITF

CLSK

HIVE

MARA

RIOT

Bitcoin Mining Data Center IREN Says It Mined 529 BTC In Dec 2024 Vs. 379 BTC In Nov 2024

Roth MKM analyst Joe Reagor initiates coverage on Brazil Potash (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GRO#AMEX">GRO</a>) with a Buy rating and announces Price Target of $17.

Initiation

Roth MKM Initiates Coverage On Brazil Potash with Buy Rating, Announces Price Target of $17

HC Wainwright &amp; Co. analyst Ed Arce maintains Arcturus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCT#NASDAQ">ARCT</a>) with a Buy and maintains $63 price target.

ARCT

HC Wainwright & Co. Maintains Buy on Arcturus Therapeutics, Maintains $63 Price Target

Morgan Stanley analyst Martijn Rats downgrades TotalEnergies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTE#NYSE">TTE</a>) from Overweight to Equal-Weight and lowers the price target from $70.4 to $64.1.

Downgrades

Morgan Stanley Downgrades TotalEnergies to Equal-Weight, Lowers Price Target to $64.1

Uber Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) shares are trading higher premarket on Tuesday after the ride-ailing company and NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) entered into a strategic partnership aimed at advancing AI-powered <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b42836060/uber-teams-up-with-nvidia-to-accelerate-autonomous-mobility" rel="noreferrer noopener">autonomous vehicle (AV) technology</a>.
The collaboration will leverage NVIDIA&#8217;s platforms, including Cosmos and DGX Cloud, to accelerate the development of autonomous driving solutions.
NVIDIA Cosmos is a state-of-the-art platform designed to support the development of physical AI systems like robots and autonomous vehicles, eliminating cost and resource limitations, making it easier for developers to build and deploy AI models at scale.
Additionally, NVIDIA DGX Cloud offers a high-performance, fully managed environment for AI model development.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/42812603/uber-cfo-highlights-undervalued-stock-while-accelerating-buyback-efforts-through-15-billion-asr-deal" rel="noreferrer noopener">Uber CFO Says Stock Undervalued, Initiates $1.5 Billion Accelerated Stock Buyback</a>
By combining Uber&#8217;s trove of mobility data with NVIDIA&#8217;s AI technology, both companies plan to create more efficient and scalable AI models for the industry.
&#8220;Generative AI will power the future of mobility, requiring both rich data and very powerful compute,&#8221;&nbsp;said Uber CEO Dara Khosrowshahi.
&#8220;By working with NVIDIA, we are confident that we can help supercharge the timeline for safe and scalable autonomous driving solutions for the industry.&#8221;
In his keynote address at the <a target="_blank" href="https://www.benzinga.com/news/global/25/01/42836461/nvidias-ces-2025-vision-sparks-mixed-reactions-ross-gerber-hails-incredible-things-to-come-while-analysts-debate-ai-and-autonomous-driving-ambitions" rel="noreferrer noopener">CES 2025 on Monday</a>, NVIDIA CEO&nbsp;Jensen Huang&nbsp;predicted that self-driving vehicles would become &#8220;the first multi-trillion dollar robotics industry.&#8221;
Nvidia will also deploy its Drive AGX&nbsp;Orin supercomputer and operating system for advanced driver assistance features on Toyota Motor Corp&#8216;s <a target="_blank" href="https://www.benzinga.com/25/01/42836673/toyotas-next-gen-vehicles-to-use-nvidia-supercomputer-operating-system" rel="noreferrer noopener">next-generation models</a>.
&#8220;NVIDIA is bringing two decades of automotive computing, safety expertise and its CUDA AV platform to transform the multitrillion dollar auto industry,&#8221; said Huang.
Price Action: UBR shares are trading higher by 2.26% at $67.81 in premarket at last check Tuesday.
Related Read:
<ul>
<li><a href="https://www.benzinga.com/tech/25/01/42801896/uber-ceo-dara-khosrowshahi-resigns-from-board-of-autonomous-vehicle-tech-company-aurora" target="_blank" rel="noreferrer noopener">Uber CEO Dara Khosrowshahi Resigns From Board Of Autonomous Vehicle Tech Company Aurora</a></li>
</ul>
Image via Shutterstock.

Equities

Movers

General

NVDA

UBER

Uber And NVIDIA Partner On AI Technology For Autonomous Cars

HC Wainwright &amp; Co. analyst Emily Bodnar maintains Acelyrin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLRN#NASDAQ">SLRN</a>) with a Neutral and lowers the price target from $8 to $6.

SLRN

HC Wainwright & Co. Maintains Neutral on Acelyrin, Lowers Price Target to $6

GETY

SSTK

Getty Images And Shutterstock Announce Merger Agreement For $3.7B

Wells Fargo &amp; Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) will release earnings for its fourth quarter before the opening <a href="https://www.benzinga.com/quote/WFC/earnings">bell on Wednesday, Jan. 15.</a>
Analysts expect the San Francisco, California-based company to report quarterly earnings at $1.34 per share, up from 86 cents per share in the year-ago period. Wells Fargo projects to report quarterly revenue of $20.6 billion, compared to $20.48 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Wells Fargo Bank, N.A. slashed its prime rate to 7.50% from 7.75%, effective Dec. 19, 2024.
Wells Fargo shares gained 2.2% to close at $72.86 on Monday&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; .
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/WFC/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>JP Morgan analyst Michael Rehaut maintained a Neutral rating and cut the price target from $92.5 to $82 on Dec. 13, 2024. This analyst has an accuracy rate of 71%.</li>
<li>Barclays analyst Matthew Bouley downgraded the stock from Overweight to Equal-Weight and cut the price target from $99 to $85 on Dec. 11, 2024. This analyst has an accuracy rate of 73%.</li>
<li>Wedbush analyst Jay McCanless maintained a Neutral rating and raised the price target from $67 to $75 on Sept. 25, 2024. This analyst has an accuracy rate of 87%.</li>
<li>B of A Securities analyst Rafe Jadrosich maintained a Neutral rating and boosted the price target from $75 to $90 on Sept. 19, 2024. This analyst has an accuracy rate of 67%.</li>
<li>RBC Capital analyst Mike Dahl downgraded the stock from Sector Perform to Underperform with a price target of $70 on Sept. 5, 2024. This analyst has an accuracy rate of 72%.</li>
</ul>
Considering buying WFC stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="603" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/07062208/image-26-1024x603.png" alt="" class="wp-image-721567" style="width:591px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/07062208/image-26-1024x603.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/07062208/image-26-300x177.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/07062208/image-26-768x453.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/07062208/image-26.png 1103w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<a href="https://www.benzinga.com/25/01/42820522/jpmorgan-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">JPMorgan Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a>

Markets

Trading Ideas

Wells Fargo Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Morgan Stanley analyst Martijn Rats maintains BP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BP#NYSE">BP</a>) with a Equal-Weight and lowers the price target from $34.7 to $31.8.

Morgan Stanley Maintains Equal-Weight on BP, Lowers Price Target to $31.8

Morgan Stanley analyst Martijn Rats downgrades Eni (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/E#NYSE">E</a>) from Overweight to Equal-Weight and lowers the price target from $37.5 to $31.6.

Morgan Stanley Downgrades Eni to Equal-Weight, Lowers Price Target to $31.6

The CNN Money Fear and Greed index showed some easing in the overall fear level, while the index remained in the &#8220;Fear&#8221; zone on Monday.
U.S. stocks settled mostly higher on Monday, with the S&amp;P 500 and Nasdaq Composite recording back-to-back gains during the session.
Chip stocks were among the top gainers of the session after Foxconn disclosed record revenue for the fourth quarter. Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) shares gained 3.4%, while Micron Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) jumped 10.5% on Monday.
Among Monday's notable headlines, The Washington Post reported Donald Trump's economic team is exploring a more targeted version of its universal tariff plan, aiming to apply tariffs to specific sectors rather than implementing a broad measure on all imports.
On the economic data front, the S&amp;P Global services PMI was revised downward to 56.8 in December compared to a preliminary reading of 58.5, and versus a reading of 56.1 in November.
Most sectors on the S&amp;P 500 closed on a negative note, with consumer staples, utilities, and real estate stocks recording the biggest losses on Monday. However, communication services and information technology stocks bucked the overall market trend, closing the session higher.
The Dow Jones closed lower by around 26 points to 42,706.56 on Monday. The S&amp;P 500 gained 0.55% to 5,975.38, while the Nasdaq Composite climbed 1.24% at 19,864.98 during Monday's session.
Investors are awaiting earnings results from RPM International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPM#NYSE">RPM</a>), AAR Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIR#NYSE">AIR</a>), and Cal-Maine Foods Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 36.7, the index remained in the &#8220;Fear&#8221; zone on Monday, versus a prior reading of 33.3.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42820522/jpmorgan-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">JPMorgan Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a></li>
</ul>
Photo courtesy: Shutterstock

Pre-Market Outlook

CALM

Nasdaq Jumps Over 1% As Nvidia, Micron Surge: Investor Fear Eases, But Greed Index Remains In 'Fear' Zone

Morgan Stanley analyst Martijn Rats upgrades Equinor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQNR#NYSE">EQNR</a>) from Equal-Weight to Overweight and raises the price target from $25.8 to $30.9.

Comments

Cadeler

Cadeler (CADLF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga